β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features. - Park, Soeun; Park, Jung Min; Park, Minsu; Ko, Dongmi; Kim, Seongjae; Seo, Juyeon; Nam, Kee Dal; Jung, Eunsun; Farrand, Lee; Kim, Yoon-Jae; Kim, Ji Young; Seo, Jae Hong (Cancer Cell International, 2022)